Immunoscintigraphy: Importance for researchers and patients

Acta Oncologica

Volumn 35, Issue 3, 1996, Pages 313-317

  Britton, Keith E ^a   Granowska, Maria ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY TC 99M;

ANTIBODY LABELING; ANTIBODY SPECIFICITY; CANCER RESEARCH; COLORECTAL CANCER; CONFERENCE PAPER; DIAGNOSTIC VALUE; HUMAN; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029941340     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609101647     Document Type: Conference Paper

References (35)

1. Granowska M, Britton KE, Mather SJ, et al. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med 1993; 20: 483-9.
2. 99mTc SM3. Eur J Nucl Med 1994; 21: 748.
3. 99mTc radioimmunoscintigraphy of colorectal cancer. Br J Cancer 1990; 62 (Suppl X): 30-3.
4. 99mTc-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results. Nucl Med Commun 1989; 10: 345-8.
5. Crippa F, Buraggi GL, Di Re E, et al. Immunoscintigraphy of ovarian cancer with the MOV18 monoclonal antibody. Eur J Cancer 1991; 27: 724-9.
6. Collier BD, Abdel-Nabi H, Doerr RJ, et al. Radioimmunoscintigraphy performed with In-111-labelled-CYT-103 in the management of colorectal cancer: comparison with CT. Radiology 1993; 185: 179-86.
7. 111In. Nucl Med Commun 1992; 13: 11-9.
8. m Mab 170H.82 in the evaluation of disease in patients with breast cancer. Eur J Nucl Med 1994; 21: 515.
9. Britton KE, Granowska M. Radioimmunoscintigraphy in tumour identification. Cancer Surv 1987; 6: 247-67.
10. Buraggi GL, Turrin A, Cascinelli N, et al. Immunoscintigraphy with antimelanoma monclonal antibodies. In: Donato L, Brilton KE, eds. Immunoscintigraphy. London: Gordon and Breach, 1985: 215-53.
11. 111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colored Dis 1989; 4: 97-108.
12. 99mTc radiolabelled monoclonal antibodies in ovarian and colorectal cancer: corrections with surgery. Nucl Med Biol 1991; 18: 413-24.
13. Granowska M, Britton KE, Mather SJ, et al. Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med 1993; 20: 690-8.
14. Kuhn JA, Corbisiero RM, Buras RR, et al. Intraperoperative gamma detection with presurgical imaging in colon cancer. Arch Surg 1991; 126: 1398-403.
15. Lind P; Lechner P; Arian-Schad K, et al. Anticarcinoembryonic antigen immunoscintigraphy (technetium-99m monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991; 32: 1319-25.
16. Doerr RJ, Abdel-Nabi H, Krag D, Mitchell E. Radiolabelled antibody imaging in the management of colorectal cancer. Arch Surg 1991; 214: 118-24.
17. Galandiuk S, Wieland HS, Moertel CG, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynaecol Obstet 1992; 174: 27-32.
18. Martin EW, Hinkle GH, Tuttle S, et al. Intraoperative radioimmunodetection of colorectal tumour with a hand held radiation detector. Am J Surg 1985; 150: 672-5.
19. Paganelli G, Stella M, Zito F, et al. Radioimmunoguided surgery using iodine-125-labelled biotinylated monoclonal antibodies and cold avidin. J Nucl Med 1994; 35: 1970-5.
20. Howell R, Morris G, Granowska M, et al. Peroperative radioimmunodetection (PROD) in colorectal cancer. Eur J Nucl Med 1994; 21: S122.
21. Epenetos AA, Britton KE, Mather SJ, et al. Targetting of iodine-123-labelled tumour associated monclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 1982; 2: 999-1004.
22. Granowska M, Britton KE, Shepherd JH, et al. A prospective study of 123-1 labelled monoclonal antibody imaging in ovarian cancer. J Clin Oncol 1986; 4: 730-46.
23. Granowska M, Shepherd J, Britton KE, et al. Ovarian cancer: diagnosis using I-123 monoclonal antibody in comparison with surgical findings. Nucl Med Commun 1984; 5: 485-99.
24. Granowska M, Mather SJ, Jobling T, et al. Radiolabelled stripped mucin SM3 monoclonal antibody for immunoscintigraphy of ovarian tumours. Int J Biol Mark 1990; 5: 89-96.
25. Granowska M, Nimmon CC, Britton KE, et al. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J Nucl Med 1988; 29: 599-607.
26. 111In-Moab-C5.3 (CYT-356) for prostate cancer. J Nucl Med 1991; 32: 1054.
27. Chengazi VU, Feneley M, Granowska M, et al. Radioimmunoscintigraphy of soft tissue recurrences of prostatic cancer with Tc-99m labelled monoclonal antibody. Eur J Nucl Med 1994; 21: 770.
28. 2 fragments. Cancer Res 1985; 45: 3378-87.
29. Siccardi AG, Buraggi GL, Callegaro L, et al. Multicentre study of immunoscintigraphy with radiolabelled monoclonal antibodies in patients with melanoma. Cancer Res 1986; 46: 4817-22.
30. 99mTc-labelled monoclonal antibody fragments. Eur J Nucl Med 1990; 16: 317-23.
31. 99mTc labelled cutaneous melanoma antibodies. Br J Ophthalmol 1987; 71: 651-8.
32. Sheritz J, Sharkey RM, Goldenberg DM. Preclinical evaluation of a chimeric and humanised anti-B-cell lymphoma antibody. J Nucl Med 1994; 35: 236.
33. Britton KE, Mather SJ, Granowska M. Radiolabelled monoclonal antibodies in oncology III radioimmunotherapy. Nucl Med Commun 1991; 12: 333-47.
34. m labelled monoclonal anti-CEA antibodies for the detection of colonie cancer - results of a world wide IAEA co-ordinated research programme. Eur J Nucl Med 1994; 21: 516.
35. Britton KE, Buraggi GL. A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Int J Biol Mark 1989; 4: 106-18.